Therapeutic BCG Vaccines Market Size Projected To Increase From $62.76 Billion To $80.4 Billion During The Forecast Period
Through market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports provide more actionable and strategically valuable research.
Therapeutic BCG Vaccines Market Revenue Growth Supported By A CAGR Of 80.4% Through 2030
The therapeutic BCG vaccines market has experienced robust expansion in recent years. Market projections indicate an increase from $59.09 billion in 2025 to $62.77 billion in 2026, reflecting a compound annual growth rate (CAGR) of 6.2%. This historic period’s growth has been driven by factors including elevated tuberculosis prevalence, intensified research into immunotherapy, constrained vaccination coverage, governmental health programs, and growing recognition of BCG’s advantages.
The therapeutic BCG vaccines market is anticipated to experience robust expansion over the coming years, projected to reach $80.4 billion by 2030 with a compound annual growth rate (CAGR) of 6.4%. This forecast period growth is driven by factors such as a growing need for customized vaccines, progress in vaccine administration technologies, an intensified emphasis on immuno-oncology uses, the broadening of public health initiatives, and increased funding for biotechnology advancements. Key developments expected during this timeframe comprise the creation of personalized BCG treatments, breakthroughs in vaccine delivery methods, enhanced research into tuberculosis immunotherapy, the use of combination therapies incorporating BCG, and immunization programs supported by government funding.
Download A Free Sample Report For Comprehensive Market Insights:
Therapeutic BCG Vaccines Market Growth Factors Supporting Long-Term Expansion
The global increase in tuberculosis (TB) cases is expected to drive the growth of the therapeutic BCG vaccine market in the coming period. TB is a potentially serious infectious disease that mainly affects the lungs, and it spreads from person to person when infected individuals cough or sneeze tiny bacterial droplets into the air. BCG vaccines work by stimulating the immune system to combat infection, but because they contain weakened germs, they do not cause the disease itself. These vaccines consistently provide protection against the most severe forms of TB, including adolescent TB meningitis. The BCG vaccine’s ability to protect against tuberculosis thereby enhances infection-fighting capacity, which has led to a heightened demand for therapeutic BCG vaccines. For example, in February 2024, a report from the UK Health Security Agency, a UK-based government authority, revealed that tuberculosis cases in England rose by 10.7% in 2023, with 4,850 reported cases compared to 4,380 in 2022. As a result, the growing number of TB cases across the globe is fueling the expansion of the therapeutic BCG vaccine market.
Therapeutic BCG Vaccines Market Segment Analysis And Revenue Opportunities
The therapeutic bcg vaccines market covered in this report is segmented –
1) By Type: Therapy BCG, Other Types
2) By Demographics: Pediatrics, Adults
3) By End Use: Hospitals, Clinics, Other End Users
Therapeutic BCG Vaccines Market Industry Trends Shaping Future Revenue Growth
Key players in the therapeutic BCG vaccine market are concentrating on developing innovative vaccines for potential therapeutic uses in various medical conditions, such as BCG immunotherapy, with the goal of broadening their customer base and addressing increasing patient demands. BCG (Bacillus Calmette-Guérin) immunotherapy involves employing the BCG vaccine as an immunotherapeutic approach to treat specific cancers, most notably bladder cancer. As an example, in July 2023, The Serum Institute of India, a biotechnology and biopharmaceutical company based in India, obtained government clearance to export its BCG vaccine to Canada for immunotherapeutic application in managing bladder cancer. This live freeze-dried formulation, produced from an attenuated strain of Mycobacterium bovis (Bacillus Calmette Guerin), is designed for intravesical administration. Available in 40 mg and 80 mg strengths, the vaccine is directly introduced into the bladder via a catheter as a key part of the treatment, where it remains in the bladder lining for a predetermined period. This specific method aims to effectively target cancer cells while reducing effects on other body areas.
Therapeutic BCG Vaccines Market Leading Players Shaping Industry Direction
Major companies operating in the therapeutic bcg vaccines market are Merck & Co Inc., Sanofi Pasteur, Japan BCG Laboratory, China National Biotec Group, Serum Institute of India Pvt. Ltd., InterVax Ltd., Statens Serum Institute, AJ Vaccines, Bul Bio-National Center of Infectious and Parasitic Diseases Ltd, Biomed Lublin S.A., PT Bio Farma, Torlak Institute of Virology, Bacille Bilie Calmette-Guerin Laboratory, Bharat Biotech International Ltd., Shanghai Institute of Biological Products Co. Ltd., Instituto Butantan, BioCen, Panacea Biotec Ltd., Institute Pasteur de Tunis, Korean BCG Vaccine Institute
Access The Complete Therapeutic BCG Vaccines Market Report:
Therapeutic BCG Vaccines Market Geographic Analysis: Where Is Demand Growing The Fastest?
Asia-Pacific was the largest region in the therapeutic BCG vaccines market in 2025. The regions covered in the therapeutic bcg vaccines market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=home_page_test
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
